Skip to main content
Log in

Carcinogene effecten van geneesmiddelen

  • Overzichtsartikelen
  • Published:
Pharmaceutisch Weekblad Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatuur

  1. Aguanho, W. D. (1974) Interpretation of results in terms of carcinogenic potential to the test animal: The regulatory point of view. In:Carcinogenesis testing of chemicals (Galberg, L., Ed.) CRC Press, Cleveland, Ohio.

    Google Scholar 

  2. Ames, B. N., J. Mccann enE. Yamasaki (1975) Methods for detecting carcinogens and mutagens with theSalmonella/mammalian chromosome mutagenicity test.Mut. Res. 31, 347.

    Google Scholar 

  3. Bridges, B. A. (1976) Short term screening tests for carcinogens.Nature 261, 36, 195.

    Google Scholar 

  4. Bridges, J., enJ. R. Fry (1978) The predictive value of biochemical tests for carcinogenicity. In:Carcinogenicity testing: Principles and problems (Dayan, A. D., enR. W. Brimblecombe, Eds.) MTP Press, Lancaster.

    Google Scholar 

  5. Brown, C. C. (1978) Statistical aspects of extrapolating of dichotomous dose-respons data.J. Natl. Cancer Inst. 60, 1, 101.

    Google Scholar 

  6. Carter, R. L. (1978) Long-term test for carcinogenicity — The pathologist's view. In:Carcinogenicity testing: Principles and problems (Dayan, A. D., enR. W. Brimblecombe, Eds.) MTP Press, Lancaster.

    Google Scholar 

  7. Cobon, A. M., L. J. Lilly enM. F. Newton (1978) Development of a technique for rapid screening of chemicals for carcinogenicity.Brit. J. Pharmacol. 32, 3, 455P.

    Google Scholar 

  8. Comité des Spécialités pharmaceutiques (1978)Securité des médicaments,agim 78/810.

  9. Conning, D. M. (1978) The economics of carcinogenicity testing. In:Carcinogeniticy testing: Principles and problems (Dayan, A. D., enR. W. Brimblecombe, Eds.) MTP Press, Lancaster.

    Google Scholar 

  10. Druckrey, H., R. Preussmann, S. Ivankovic enD. Schmähl (1967) Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitrosoverbindungen an BDRatten.Z. Krebsforsch. 69, 103.

    Google Scholar 

  11. Eckardt, R. E. (1976) Extrapolating from animals to man: Carcinogenesis.J. Occup. Med. 18, 7, 492.

    Google Scholar 

  12. Emmelot, P., enE. Scherer (1977) Multi-hit kinetics of tumor formation, with special reference to experimental liver and human lung carcinogenesis and some general conclusions.Cancer Res. 37, 1702.

    Google Scholar 

  13. Friedman, L. (1973)Problems of evaluating the health significance of the chemicals present in foods. Proceedings of the 5th International Congress of Pharmacology, San Francisco, 2, 30, Karger, Basel.

    Google Scholar 

  14. Golberg, L. (1974)Carcinogenesis testing of chemicals, Editorial. CRC Press, Cleveland, Ohio.

    Google Scholar 

  15. Green, M. H. L. (1978) The predictive value of microbiological tests for carcinogenicity. In:Carcinogenicity testing: Principles and problems (Dayan, A. D., enR. W. Brimblecombe, Eds.) MTP Press, Lancaster.

    Google Scholar 

  16. IARC (1973) Monographs on the evaluation of carcinogenic risk of chemicals to man,Some inorganic and organometallic compounds, Vol. 2. IARC/WHO, Lyon.

    Google Scholar 

  17. IARC (1974) Monographs on the evaluation of carcinogenic risk of chemicals to man,Sex hormones, Vol. 6. IARC/WHO, Lyon.

    Google Scholar 

  18. IARC (1975) Monographs on the evaluation of carcinogenic risk of chemicals to man,Some aziridines, N-, S-& O-mustards and selenium, Vol. 9. IARC/WHO, Lyon.

    Google Scholar 

  19. IARC (1976) Monographs on the evaluation of carcinogenic risk of chemicals to man,Some naturally occuring substances, Vol. 10. IARC/WHO, Lyon.

    Google Scholar 

  20. IARC (1977) Monographs on the evaluation of carcinogenic risk of chemicals to man,Some miscellaneous pharmaceutical substances. Vol. 13. IARC/WHO, Lyon.

    Google Scholar 

  21. Ivankovic, S. (1977) Entstehung karzinogener Nitrosoverbindungen im Magen.Med. Klin. 72, 9, 366.

    Google Scholar 

  22. Jones, G. (1978) Problems facing the regulatory authorities. In:Carcinogenicity testing: Principles and problems (Dayan, A. D.,enR. W. Brimblecombe, Eds.) MTP Press, Lancaster.

    Google Scholar 

  23. Kolata, G. B. (1976) Chemical carcinogens: Industry adopts controversial quick tests.Science, 192, 1215.

    Google Scholar 

  24. Maes, R. A. A. (1976) Collegedictaat toxicologie, deel 1, Utrecht.

  25. Mantel, N., enW. R. Bryan (1961) Safety testing of carcinogenic agents.J. Natl. Cancer Inst. 27, 455.

    Google Scholar 

  26. Miller, E. C., J. A. Miller enM. Enomoto (1964) The comparative cancerogenicities of 2-acetylaminofluorene and its N-hydroxy-metabolite in mice, hamsters and guinea pigs.Cancer Res. 24, 2084.

    Google Scholar 

  27. Miller, J. A. (1970) Carcinogenesis by chemicals: An overview.Cancer Res. 30, 3, 559.

    Google Scholar 

  28. Montesano, R. (1978) The use of mutagenicity tests in screening chemical carcinogens. In:Prog. Biochem. Pharmacol. 14, 157, Karger, Basel.

    Google Scholar 

  29. Mulder, G. J. (1978) Ontstaan en aantonen van carcinogene en mutagene metabolieten.Pharm. Weekblad 113, 637.

    Google Scholar 

  30. Muul, I., A. F. Hegyeli, J. C. Dacre enG. Woodard (1976) Toxicological testing dilemma.Science 193, 834.

    Google Scholar 

  31. Peck, H. M. (1974) Design of experiments to detect carcinogenic effects of drugs. In:Carcinogenesis testing of chemicals (Golberg, L., Ed.) CRC Press, Cleveland, Ohio.

    Google Scholar 

  32. Pott, P. (1918) Chirurgical observations relative to the cancer of the scrotum, 1775. Reprinted inNatl. Cancer Res. 3, 1.

    Google Scholar 

  33. Roe, F. J. C. enM. J. Tucker (1973) Recent developments in the design of cancerogenicity tests on laboratory animals.Proc. Europ. Soc. Study Drug Toxicity 15, 171.

    Google Scholar 

  34. Ruser, H. J. P. (1971) Chemical carcinogenesis.New Engl. J. Med. 283, 13, 721.

    Google Scholar 

  35. Sarma, D. S. R. (1974) Chemical interaction measurements. In:Carcinogenesis testing of chemicals (Golberg, L., Ed.) CRC Press, Cleveland, Ohio.

    Google Scholar 

  36. Slater, E. E., M. D. Anderson enH. S. Rosenkranz (1971) Rapid detection of mutagens and carcinogens.Cancer Res. 31, 970.

    Google Scholar 

  37. Stevenson, D. E., E. Thorpe enP. F. Hunt (1978) The predictive value or otherwise of conventional carcinogenicity studies. In:Carcinogenicity testing: Principles and problems (Dayan, A. D., enR. W. Brimblecombe, Eds.) MTP Press, Lancaster.

    Google Scholar 

  38. Tomatis, L., C. Agthe, H. Bartsch, J. Huff, R. Montesano, R. Saracci, E. Walker enJ. Wilbourn (1978) Evaluation of the carcinogenicity of chemicals: A review of the program of the IARC.Cancer Res. 38, 4, 877.

    Google Scholar 

  39. Vos, D. De (1978) Platina-complexen als geneesmiddel tegen kanker.Chem. Weekblad 74, 713.

    Google Scholar 

  40. Weil, C. S. (1972) Statistics versus safety factors and scientific judgement in the evaluation of safety for man.Toxicol. Appl. Pharmacol. 21, 454.

    Google Scholar 

  41. Weisburger, E. K. (1977) Bioassay program for carcinogenic hazards of cancer chemotherapeutic agents.Cancer 40, Suppl. 1977, 1935.

    Google Scholar 

  42. Weisburger, K. A. (1975) A critical evaluation of the methods used for determining carcinogenicity.J. Clin. Pharmacol., 1, 5.

    Google Scholar 

  43. Weinstein, B. (1974) Tissue culture techniques. In:Carcinogenesis testing (Golberg, L., Ed.) CRC Press, Cleveland, Ohio.

    Google Scholar 

  44. Wetgeving betreffende geneesmiddelen, Uitvoeringsvoorschriftenci-iia, 43, Vermande Zonen, IJmuiden. 45. WHO Scientific Group on Guidelines for evaluation of drugs for use in man (1975) WHOTechn. Rep. Ser., No. 563.

  45. WHO (1969) Scientific Group on Principles for the testing and evaluation of drugs for cancerogenicity, WHOTechn. Rep. Ser., No. 246.

  46. Yamagiwa, K.,enK. Ichikawa (1918) Experimental study on the pathogenesis of carcinoma.J. Cancer Res. 3, 1.

    Google Scholar 

Download references

Authors

Additional information

Naar een scriptie geschreven onder verantwoordelijkheid van Prof. Dr. R. R. R.Maes, hoogleraar Toxicologie te Utrecht.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Kollenburg, C.P.A.H.M. Carcinogene effecten van geneesmiddelen. Pharmaceutisch Weekblad Scientific Edition 2, 317–330 (1980). https://doi.org/10.1007/BF02273007

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02273007

Navigation